Stryker Corporation has a robust track record of double-digit earnings growth and high single-digit organic revenue growth.

We recently published a list of 8 High Growth UK Stocks to Invest In. In this article, we are going to take a look at where ...

Industry leaders explored the risks and benefits of adopting a China Plus One strategy at Advamed’s The MedTech Conference in ...

Medtech Innovator announced that it awarded the grand prize for its early-stage accelerator to AI-driven tech developer Samay ...

Definitive Healthcare (Nasdaq: DH), a leader in healthcare commercial intelligence, today announced the launch of Monocl Conferences. This solution is designed to enhance conference planning and ...

Tarver took the position in late July after the announcement that CDRH’s director of the past 15 years, Jeff Shuren, M.D., ...

Johnson & Johnson MedTech (NYSE: JNJ) today announced the first completed commercial case with its Varipulse platform in ...

The pediatric cardiology innovations include monitoring systems, handheld devices for imaging and diagnostics, and a ...

Johnson & Johnson's innovative medicines division shows promise with expected revenues of $57bn by 2025. See more about JNJ ...

Johnson & Johnson (NYSE: JNJ) recently reported its Q3 results, with revenues and earnings exceeding our estimates.

The healthcare company's 3%-yielding dividend (more than double the S&P 500 's dividend yield) is as healthy as you'll find.

A shortage of intravenous (IV) saline fluids due to Hurricane Helene is forcing hospitals to defer non-urgent surgeries, and could hurt companies that make medical devices for elective procedures if ...